M
Milestone Pharmaceuticals Inc. (MIST)
NMS – Real Time Price. Currency in USD
1.24
-0.01 (-0.80%)
At close: Jun 26, 2026, 4:00 PM EDT
1.25
+0.01 (0.81%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
1.24
-0.01 (-0.80%)
At close: Jun 26, 2026, 4:00 PM EDT
1.25
+0.01 (0.81%)
After-hours: Jun 26, 2026, 7:59 PM EDT
No Data
There are no news for this stock.
Total debt $137.3M significantly exceeds cash reserves ($71.3M), raising financial stability concerns
Total current assets $192.3M exceed Total current liabilities $20.9M, highlighting excellent liquidity
Debt-to-equity ratio (3.8) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (-5.7x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$16.1M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 9.18 | 6.05 | 10 | |
| Quick ratio | 9.09 | 5.63 | 10 | |
| Debt to Equity | 3.81 | 0.30 | 2.0 | |
| Debt to Assets | 0.71 | 1.04 | 3.0 | |
| Interest coverage | -5.75 | -16.91 | 1.0 | |
| Weighted average score | 5.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 5M | 1M | N/A | 2M | 2M |
| Gross Profit | 5M | 402K | -646K | 1M | 2M |
| Operating Income | -60M | -61M | -42M | -62M | -66M |
| Net Income | -58M | -60M | -42M | -63M | -68M |
| EBITDA | -60M | -61M | -42M | -62M | -65M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 6.67 | 3.0 |
| Next quarter | N/A | -73.61 | 1.0 |
| Current year | 358.85 | -24 | 5.5 |
| Next year | 315.07 | -9.86 | 5.5 |
| Weighted average score | 3.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -84.6 | -49.72 | -24.99 | -27.71 | 1.0 |
| Y/Y | 999 | -25.54 | 35.48 | -15.32 | 5.5 |
| 3y average | 273.01 | -7.87 | 13.05 | -7.03 | 5.0 |
| 5y average | 350.27 | -9.12 | 8.78 | -9.06 | 4.5 |
| Weighted average score | 4.0 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |